Journal of Iranian Medical Council

Journal of Iranian Medical Council

Multiplex PCR for Rapid and Accurate Diagnosis of Bloodstream Pathogens in Patients with Suspected Sepsis

Document Type : Original article

Authors
1 Department of Infectious Diseases, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
2 Department of Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
3 Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran
Abstract
Background: Timely diagnosis of Bloodstream Infections (BSIs) is crucial for effective sepsis management. Conventional culture methods, though considered the gold standard, exhibit limitations. This study aimed to evaluate the efficacy of multiplex Polymerase Chain Reaction (PCR) for rapid and accurate detection of bloodstream pathogens in suspected sepsis patients. 
Methods: The study was conducted between March 2021 and March 2022 at Valiasr Hospital, Zanjan, Iran. One hundred patients with suspected sepsis were recruited, and blood samples were collected for both methods. Demographic and clinical data were collected, and genomic DNA was extracted for PCR. Data were analyzed using SPSS software. 
Results: Most patients were elderly (>60 years), and Multiplex-PCR demonstrated higher detection rates than culture. Age, antibiotic history, and infection site were associated with bacterial frequency. A significant relationship existed between bacterial frequency and patient outcome. Pulmonary infections were most common, with specific imaging patterns observed.
Conclusion: Multiplex PCR is a rapid and sensitive tool for diagnosing sepsis, offering superior sensitivity compared to culture. Further research is needed to validate its broader clinical application.
Keywords

Subjects


Abstract
Background: Timely diagnosis of Bloodstream Infections (BSIs) is crucial for effective sepsis management. Conventional culture methods, though considered the gold standard, exhibit limitations. This study aimed to evaluate the efficacy of multiplex Polymerase Chain Reaction (PCR) for rapid and accurate detection of bloodstream pathogens in suspected sepsis patients. 
Methods: The study was conducted between March 2021 and March 2022 at Valiasr Hospital, Zanjan, Iran. One hundred patients with suspected sepsis were recruited, and blood samples were collected for both methods. Demographic and clinical data were collected, and genomic DNA was extracted for PCR. Data were analyzed using SPSS software. 
Results: Most patients were elderly (>60 years), and Multiplex-PCR demonstrated higher detection rates than culture. Age, antibiotic history, and infection site were associated with bacterial frequency. A significant relationship existed between bacterial frequency and patient outcome. Pulmonary infections were most common, with specific imaging patterns observed.
Conclusion: Multiplex PCR is a rapid and sensitive tool for diagnosing sepsis, offering superior sensitivity compared to culture. Further research is needed to validate its broader clinical application.
Keywords: Bacteria, Demography, DNA, Hospitals, Iran, Multiplex polymerase chain reaction, Sepsis, Genomics

Introduction
Sepsis, a life-threatening condition characterized by a Systemic Inflammatory Response Syndrome (SIRS) following infection, remains a significant public health challenge worldwide (1,2). Early and accurate diagnosis of Bloodstream Infections (BSIs) is crucial for promptly initiating appropriate antimicrobial therapy, the cornerstone of sepsis management (3). While considered the gold standard for BSI diagnosis, conventional culture-based methods have limitations, including extended Turnaround Times (TATs), susceptibility to contamination, and suboptimal sensitivity when samples are obtained from patients on antibiotics. These limitations emphasize the need for rapid and accurate diagnostic tools to guide timely treatment decisions and improve patient outcomes (4,5). 
In recent years, multiplex Polymerase Chain Reaction (PCR) has emerged as a promising alternative for rapidly and sensitively detecting pathogens in blood specimens (6). Multiplex PCR assays amplify multiple target sequences simultaneously, enabling the detection of a broader range of pathogens in a single reaction (7). Compared to conventional culture methods, multiplex PCR offers several advantages, including faster TATs, reduced risk of contamination, and the ability to detect fastidious or antibiotic-resistant pathogens (8). Several studies have evaluated the performance of multiplex PCR for diagnosing BSIs in patients with suspected sepsis. These studies have demonstrated that multiplex PCR can achieve high sensitivity and specificity comparable to or even better than conventional culture methods (9-11). Moreover, multiplex PCR has been shown to identify pathogens that culture may miss, particularly in patients receiving antibiotics (12). 
The introduction of multiplex PCR assays can potentially transform the diagnosis and management of BSIs (13). By providing rapid and accurate pathogen identification, multiplex PCR can enable the timely initiation of appropriate antimicrobial therapy, potentially improving patient outcomes and reducing healthcare costs (14). Therefore, this study aims to rigorously evaluate and compare the diagnostic efficacy of traditional bacterial culture and modern multiplex PCR in identifying sepsis-causing micro-organisms. Also, this study provides a comprehensive understanding of the demographic and clinical factors associated with sepsis and seeks to unravel critical associations influencing sepsis outcomes. The findings of this study may pave the way for the broader implementation of multiplex PCR in routine clinical practice, potentially transforming the landscape of sepsis diagnosis and management.

Materials and Methods
Patient recruitment and sample collection
This cross-sectional study included 100 patients with suspected sepsis admitted to the Infectious Diseases Department of Valiasr Hospital, Zanjan, Iran, between March 2021 and March 2022. Convenience sampling was used to recruit patients aged 17 to 96 years. Due to the limited study duration and access to eligible patients during hospitalization, this type of sampling was used. Inclusion criteria were suspected sepsis based on clinical signs, laboratory findings, and absence of antibiotic treatment within 48 hr before sample collection. Two blood samples were drawn per patient: 8-10 ml of venous blood for conventional blood cultures and 2 ml of EDTA-treated whole blood for molecular analysis. Samples were collected under aseptic conditions, each set taken from the same venipuncture to minimize patient discomfort and prevent contamination.

Infection control protocols
Standard infection control practices were followed to ensure consistency in clinical management and reduce contamination risks, including daily patient bathing if needed, regular intravenous line changes every 72 hr, and strict adherence to debridement protocols for burn wounds. Carbapenems were the primary empiric choice in cases of suspected sepsis. These protocols were implemented to limit biases related to institutional practices. The infection control protocols followed were based on the standard guidelines of the Infection Control Committee of Valiasr Hospital, adapted from the Centers for Disease Control and Prevention (CDC) guidelines for infection prevention (15).

Microbiological culture methods
Blood culture samples were inoculated into aerobic and anaerobic bottles with tryptic soy broth containing SPS anticoagulant. Cultures were incubated using the automated Bactec blood culture system (Becton Dickinson, USA) at 35°C for up to seven days. Samples exhibiting microbial growth were subjected to Gram staining, subculturing, and identification according to standard microbiological procedures. No selective media were used in this process to avoid excluding potentially relevant pathogens.

Multiplex PCR for pathogen detection
Genomic DNA was extracted from EDTA whole blood samples using the GeneAll Blood DNA extraction kit following the manufacturer’s protocol, which involved cell lysis, protein digestion, and elution of purified DNA. The quality and purity of extracted DNA were verified by NanoDrop spectrophotometry (Thermo Scientific, USA), with an optimal 260/280 ratio of approximately 1.8. Additionally, DNA integrity was assessed by gel electrophoresis (0.8% agarose gel) (16)​. PCR amplification targeted five major bloodstream pathogens frequently associated with sepsis: Staphylococcus aureus (S. aureus), Staphylococcus epidermidis (S. epidermidis), Pseudomonas aeruginosa (P. aeruginosa), Escherichia coli (E. coli), and Klebsiella pneumonia (K. pneumoniae). Specific primers were designed for the following genes: femA (S. aureus), sesC (S. epidermidis), oprL (P. aeruginosa), K1 (K. pneumoniae), and MetH (E. coli). Primers were synthesized by Metabion (Germany) and are detailed in table 1. PCR was conducted on a SimpliAmp thermal cycler (Applied Biosystems, USA) with the following parameters: initial denaturation at 95°C for 5 min, followed by 30 cycles of denaturation at 95°C for 25 s, primer annealing at optimal temperatures for 40 s, and extension at 72°C for 50 s. A final extension was performed at 72°C for 6 min. Amplification products were visualized on a 1.5% agarose gel stained with ethidium bromide (17).

Ethical approval
The Ethics Committee of Zanjan University of Medical Sciences (IR.ZUMS.REC.1399.451) approved the study protocol. All eligible patients gave oral informed consent before participating in the study.

Data collection and analysis
Demographic and clinical data were collected using a structured questionnaire, including age, gender, risk factors (e.g., immunodeficiency, chronic diseases, prosthetic implants), clinical symptoms, and imaging results. Statistical analyses were conducted using SPSS 22 (IBM Corp., Armonk, NY, USA). The distribution of continuous variables was assessed using the Shapiro-Wilk test and histogram plots. Categorical variables were analyzed using Chi-square or Fisher’s exact tests. A p-value of <0.05 was considered statistically significant.

Results
Demographic characteristics of patients
The study included 100 patients aged between 17 and 96 years. The majority of patients, 74 cases (74%), were over 60 years old. Sixteen patients (16%) were aged 41–60, while 10 patients (10%) were under the age of 40. In terms of residency, 71 patients resided in urban areas and 29 in rural areas.

Comparison of PCR and culture for pathogen detection
Multiplex PCR results were obtained within 4–6 hr after blood sample collection, enabling faster clinical decision-making. The bacterial pathogens detected included S. aureus, S. epidermidis, P. aeruginosa, E. coli, and K. pneumoniae. PCR showed higher sensitivity compared to culture, detecting more pathogens overall. Table 2 provides a detailed comparison of detection frequencies between PCR and culture methods.

Bacterial distribution according to gender
Analysis showed a statistically significant relationship between gender and the frequency of S. epidermidis (p=0.001). However, no significant gender-based differences were observed for the other pathogens (S. aureus, E. coli, K. pneumoniae, and P. aeruginosa). Details are presented in table 3.

Antibiotic history and pathogen distribution
Of the 100 patients, seven had received antibiotics prior to hospitalization, while 93 had not. A significant association was found between previous antibiotic use and the detection of S. epidermidis, E. coli, K. pneumoniae, and P. aeruginosa (p=0.001). This finding suggests prior antibiotic exposure may influence pathogen distribution. 

Clinical outcomes and pathogen frequency
Clinical outcomes included 56 deaths, 42 recoveries, and 2 ICU admissions. A statistically significant relationship was identified between patient outcome and the frequency of all five bacterial species (p<0.05), as summarized in table 5. These findings highlight the prognostic value of pathogen detection in septic patients.

Infection site and pathogen prevalence
Pulmonary infections were the most frequent (31 cases), followed by cardiac/pulmonary (14 cases), pulmonary/hepatic (8 cases), and pulmonary/renal (8 cases). A significant association was observed between the infection site and the frequency of E. coli (p<0.001), K. pneumoniae (p<0.001), and P. aeruginosa (p=0.038). Table 6 presents the infection site distribution in detail.

Imaging findings
Chest radiographs and CT scans revealed pulmonary abnormalities in 86 patients. The most common radiological findings were pleural effusion, followed by reticular opacities and Ground-Glass Opacities (GGO). These results indicate that pulmonary involvement is a predominant feature in patients with suspected sepsis.

Table 1. Primers sequences used for amplification of specific genes

References

Size (bp)

Sequences 5′ → 3′

 

Primers

(39)

132

AAAAAAGCACATAACAAGCG

Forward

femA

GATAAAGAAGAAACCAGCAG

Reverse

femA

(40)

388

GTTGATAACCGTCAACAAGG

F

sesC

CATGTTGATCTTTTGAATCCC

R

SesC

(41)

131

AACAGCGGTGCCGTTGAC

F

oprL

GTCGGAGCTGTCGTACTCGAA

R

oprL

(42)

1283

GGTGCTCTTTACATCATTGC

F

K1

GCAATGGCCATTTGCGTTAG

R

K1

(43)

106

CGTGGTGGTCGCTTTTACCACAGAT

F

MetH

TCCACTTTGCTGCTCACACTTGCTC

R

MetH

 

 

Table 2. Summary of bacterial detection by Multiplex PCR and culture, stratified by demographics, antibiotic history, and outcome

Variable

S. aureus

S. epidermidis

E. coli

K. pneumoniae

P. aeruginosa

Detection method

Culture: 1
PCR: 6

Culture: 7
PCR: 8

Culture: 0
PCR: 4

Culture: 2
PCR: 6

Culture: 3
PCR: 8

Gender (positive cases)

Male: 1
Female: 5
p=0.092

Male: 3
Female: 5
p=0.001

Male: 2
Female: 2
p=0.920

Male: 3
Female: 3
p=0.940

Male: 4
Female: 4
p=0.912

Antibiotic history (positive cases out of patients with vs. without prior antibiotic use)

0 out of 7
vs. 6 out of 93
p=0.914

1 out of 7
vs. 7 out of 93
p=0.001

0 out of 7
vs. 4 out of 93
p=0.001

0 out of 7
vs. 6 out of 93
p=0.001

1 out of 7
vs. 7 out of 93
p=0.001

Outcome (positive cases)

Improved: 4
ICU: 0
Deceased: 2
p=0.001

Improved: 2
ICU: 0
Deceased: 6
p=0.001

Improved: 0
ICU: 0
Deceased: 4
p=0.001

Improved: 2
ICU: 0
Deceased: 4
p=0.001

Improved: 1
ICU: 1
Deceased: 6
p=0.028

* p-value level based on Fisher’s Exact Test; Staphylococcus aureus (S. aureus), Staphylococcus epidermidis (S. epidermidis), Pseudomonas aeruginosa (P. aeruginosa), Escherichia coli (E. coli), and Klebsiella pneumonia (K. pneumoniae).

 

Table 3. Frequency of sources of infection by type of bacteria

Bacterial infection

 

Sources of infection

S. aureus

S. epidermidis

E. coli

K. pneumoniae

P. aeruginosa

P

N

P

N

P

N

P

N

P

N

Pulmonary

2

29

3

28

1

30

1

30

2

29

Hepatic

1

0

0

1

0

1

0

1

0

1

Pulmonary/hepatic

2

6

2

6

0

8

0

8

0

8

Cardiac/pulmonary

0

14

0

14

1

13

2

12

1

13

Hepatic/renal

0

2

0

2

0

2

1

1

0

2

Pulmonary/kidney

0

8

1

7

2

6

0

8

0

8

Pulmonary/articular

1

1

0

2

0

2

0

2

0

2

Pulmonary/nervous

0

5

0

5

0

5

1

4

3

2

Pulmonary/cutaneous

0

2

0

2

0

2

1

1

0

2

Cardiac/pulmonary/renal

0

1

1

0

0

1

0

1

0

1

Pulmonary/kidney/skin

0

1

0

1

0

1

0

1

1

0

other

0

25

1

24

0

25

6

27

1

24

p-value

0.068

0.075

<0.001

<0.001

0.038

Staphylococcus aureus (S. aureus), Staphylococcus epidermidis (S. epidermidis), Pseudomonas aeruginosa (P. aeruginosa), Escherichia coli (E. coli), and Klebsiella pneumonia (K. pneumoniae).

 

Table 4. Frequency of bacterial strains based on history of antibiotic use

Taking antibiotics

Bacterial infection

Have number (%)

Does not have number (%)

p-value*

S. aureus

Positive

0(0)

6(6)

0.914

Negative

7(7)

87(87)

S. epidermidis

Positive

1(1)

7(7)

0.001

Negative

6(6)

86(86)

E. coli

Positive

0(0)

4(4)

0.001

Negative

7(7)

89(89)

K. pneumoniae

Positive

0(0)

6(6)

0.001

Negative

7(7)

87(87)

P. aeruginosa

Positive

1(1)

7(7)

0.001

Negative

6(6)

86(86)

 * p-value level based on Fisher’s Exact Test.

 

Table 5. Relationship between the outcome and the abundance of bacteria (Frequency of bacterial strains according to outcome)

Age group

 

                       Bacterial infection

Improved number (%)

ICU- required number (%)

Deceased number (%)

p-value*

S. aureus

Positive

4(4)

0(0)

2(2)

0.001

Negative 

38(38)

2(2)

54(54)

S. epidermidis

Positive

2(2)

0(0)

6(6)

0.001

Negative 

40(40)

2(2)

50(50)

E. coli

Positive

0(0)

0(0)

4(4)

0.001

Negative 

42(42)

2(2)

52(52)

K. pneumoniae

 

Positive

2(2)

0(0)

4(4)

0.001

Negative 

40(40)

2(2)

52(52)

P. aeruginosa

Positive

1(1)

1(1)

6(6)

0.028

Negative 

41(41)

1(1)

50(50)

* p-value based on Chi-square Test.

 

Table 6. Frequency of sources of infection by type of bacteria

Bacterial infection

 

Sources of infection

S. aureus

S. epidermidis

E. coli

K. pneumoniae

P. aeruginosa

P

N

P

N

P

N

P

N

P

N

pulmonary

2

29

3

28

1

30

1

30

2

29

Hepatic

1

0

0

1

0

1

0

1

0

1

Pulmonary/Hepatic

2

6

2

6

0

8

0

8

0

8

Cardiac/Pulmonary

0

14

0

14

1

13

2

12

1

13

Hepatic/renal

0

2

0

2

0

2

1

1

0

2

Pulmonary/kidney

0

8

1

7

2

6

0

8

0

8

Pulmonary/articular

1

1

0

2

0

2

0

2

0

2

Pulmonary/nervous

0

5

0

5

0

5

1

4

3

2

Pulmonary/cutaneous

0

2

0

2

0

2

1

1

0

2

Cardiac/Pulmonary/Renal

0

1

1

0

0

1

0

1

0

1

Pulmonary/kidney/skin

0

1

0

1

0

1

0

1

1

0

Other

0

25

1

24

0

25

6

27

1

24

p-value

0.068

0.075

<0.001

<0.001

0.038

Discussion
In this study, the aim was to evaluate the utility of multiplex PCR for the rapid and accurate detection of bloodstream pathogens in patients with suspected sepsis. The results revealed that most patients included in the study were elderly, a pattern that has also been observed in previous studies (18-20). Interestingly, consistent with other studies, the PCR results demonstrated a higher detection rate of bacterial pathogens than traditional culture methods, suggesting the superior sensitivity of molecular testing in identifying bloodstream pathogens (21-23). 
Although various studies around the world have identified various bacteria as the most common cause of sepsis (24,25), the present study is consistent with the findings of Gheybi et al, Tabatabaei et al, and Ghadiri et al. coagulase-negative Staphylococcus and P. aeruginosa identified as the most common cause of sepsis (26-28). 
The findings of the present study also highlighted significant associations between patient demographics and the frequency of bacterial strains. Specifically, a notable relationship was observed between age and the prevalence of bacterial pathogens, indicating a potential age-related susceptibility to bloodstream infections. These results align with the findings of several studies conducted in America, Taiwan, and Saudi Arabia (29-31). Additionally, the history of antibiotic use was significantly correlated with the frequency of specific bacterial strains, underscoring the influence of prior antibiotic exposure on microbial composition in septic patients (32-34). Furthermore, the study identified a significant correlation between the outcome of sepsis patients and the frequency of bacterial pathogens. Consistent with previous literature, our results suggest that the presence of specific bacterial strains may contribute to the severity and mortality of sepsis cases (35). 
Moreover, the infection site was associated with the prevalence of particular bacterial species, emphasizing the importance of understanding infection localization for targeted treatment strategies (36,37). Notably, pulmonary infections were the most common type of infection observed in the present study cohort, with imaging findings indicative of pleural effusion and distinct patterns such as reticular and GGO patterns. These findings align with previous reports highlighting the prevalence of pulmonary involvement in septic patients, emphasizing the need for prompt diagnosis and management of respiratory complications in sepsis (37,38). 
In summary, the present study underscores the potential of multiplex PCR as a valuable tool for the rapid and accurate detection of bloodstream pathogens in patients with suspected sepsis. The findings contribute to the growing body of evidence supporting the use of molecular diagnostics in improving the timely identification and management of septic patients, ultimately facilitating better clinical outcomes. 

Limitations
The small sample size may limit the generalizability of the findings, and larger cohorts are necessary to validate the broader application of the multiplex PCR method. Also, relying on data from a single center may introduce institutional biases, and a multicenter approach may increase the external validity of the results. Although demographic associations were explored, deeper correlations between molecular findings and specific clinical outcomes were not extensively studied, leaving room for further exploration. Furthermore, the use of convenience sampling may have introduced selection bias, potentially limiting the generalizability of the findings. Additionally, due to the lack of per-patient matched data between PCR and culture results, sensitivity and specificity could not be calculated. Future studies should include individual-level diagnostic comparisons to enable such analysis. These limitations emphasize the need for future research efforts to address these limitations and strengthen the evidence base supporting the implementation of multiplex PCR for diagnosing sepsis.

Conclusion
The present study demonstrates the utility of multiplex PCR as a rapid and sensitive diagnostic tool for identifying bloodstream pathogens in patients with suspected sepsis. The results highlight the superior sensitivity of multiplex PCR over traditional culture methods, with a higher detection rate of bacterial pathogens. Significant associations between patient demographics, antibiotic history, and outcomes emphasize the multifactorial nature of sepsis. The study underscores the potential of multiplex PCR to transform sepsis diagnosis and management by providing timely and accurate pathogen identification, contributing to improved patient outcomes. Further research and implementation studies are warranted to establish the broader integration of multiplex PCR into routine clinical practice, thereby enhancing the sepsis diagnosis and treatment landscape.

Funding
No funding was received for this study.
Ethical approval
The Ethics Committee of Zanjan University of Medical Sciences (IR.ZUMS.REC.1399.451) approved the study protocol. All eligible patients gave oral informed consent before participating in the study.

Acknowledgement 
We would like to thank the technical support of Zanjan University of Medical Sciences and the staff of the Burn and Regenerative Research Center of Guilan University of Medical Sciences.

Conflict of Interest
The authors declare no conflict of interest.

1. De Jong HK, Van Der Poll T, Wiersinga WJ. The systemic pro-inflammatory response in sepsis. J Innate Immun 2010;2(5):422-30. https://pubmed.ncbi.nlm.nih.gov/20530955/
2. Perner A, Gordon AC, De Backer D, Dimopoulos G, Russell JA, Lipman J, et al. Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy. Intensive Care Med 2016;42:1958-69. https://pubmed.ncbi.nlm.nih.gov/27695884/
3. Florio W, Morici P, Ghelardi E, Barnini S, Lupetti A. Recent advances in the microbiological diagnosis of bloodstream infections. Crit Rev Microbiol 2018;44(3):351-70. https://pubmed.ncbi.nlm.nih.gov/29185372/
4. Loonen A, Wolffs P, Bruggeman C, Van den Brule A. Developments for improved diagnosis of bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 2014;33:1687-702. https://pubmed.ncbi.nlm.nih.gov/24848132/
5. Hedayati Ch M, Mobayen M, Feizkhah A, Sadeghi M. Machine learning for assessment of antimicrobial susceptibility: A novel bioinformatics approach against antimicrobial resistance. Journal of Nursing Reports in Clinical Practice 2024 Apr 1;2(2):114-5.
6. Du Y, Yan Z, Song K, Jin J, Xiao L, Sun Z, et al. Development and evaluation of a multiplex droplet digital polymerase chain reaction method for simultaneous detection of five biothreat pathogens. Front Microbiol 2022;13:970973. https://pubmed.ncbi.nlm.nih.gov/35966705/
7. Yan W. Multiplex PCR primer design for simultaneous detection of multiple pathogens. Methods Mol Biol 2015;1275:91-101.  https://pubmed.ncbi.nlm.nih.gov/25697653/
8. Rathore K, Joseph B, Sharma D, Gaurav A, Sharma S, Milind M, et al. Evaluation of multiplex polymerase chain reaction as an alternative to conventional antibiotic sensitivity test. Vet World 2018;11(4):474-9. https://pubmed.ncbi.nlm.nih.gov/29805213/
9. Ziegler I, Fagerström A, Strålin K, Mölling P. Evaluation of a commercial multiplex PCR assay for detection of pathogen DNA in blood from patients with suspected sepsis. PloS One 2016;11(12):e0167883. https://pubmed.ncbi.nlm.nih.gov/27997618/
10. Omar S, Murphy S, Gheevarghese R, Poppleton N. A retrospective evaluation of a multiplex polymerase chain reaction test directly applied to blood for the management of sepsis in the critically ill. South Afr J Crit Care 2021;37(3):115-8. https://pubmed.ncbi.nlm.nih.gov/35517850/
11. Van De Groep K, Bos MP, Savelkoul PH, Rubenjan A, Gazenbeek C, Melchers WJ, et al. Development and first evaluation of a novel multiplex real-time PCR on whole blood samples for rapid pathogen identification in critically ill patients with sepsis. Eur J Clin Microbiol Infect Dis 2018;37:1333-44. https://pubmed.ncbi.nlm.nih.gov/29700761/
12. Baudel JL, Tankovic J, Dahoumane R, Carrat F, Galbois A, Ait-Oufella H, et al. Multiplex PCR performed of bronchoalveolar lavage fluid increases pathogen identification rate in critically ill patients with pneumonia: a pilot study. Ann Intensive Care 2014;4:1-9. https://pubmed.ncbi.nlm.nih.gov/25593751/
13. Chaidaroglou A, Manoli E, Marathias E, Gkouziouta A, Saroglou G, Alivizatos P, et al. Use of a multiplex polymerase chain reaction system for enhanced bloodstream pathogen detection in thoracic transplantation. J Heart Lung Transplant 2013;32(7):707-13. https://pubmed.ncbi.nlm.nih.gov/23796153/
14. Pettit N, Han Z, Charnot-Katsikas A, Pisano J, Tesic V. Impact of rapid microorganism identification using two multiplex PCR platforms on timing of antimicrobial therapy. J Infect Dis Epidemiol 2019;5:069.
15. Update R, Talbot T. Healthcare Infection Control Practices Advisory Committee (HICPAC) Agenda. 2017.
16. Shams SS, Vahed SZ, Soltanzad F, Kafil V, Barzegari A, Atashpaz S, et al. Highly effective DNA extraction method from fresh, frozen, dried and clotted blood samples. BioImpacts 2011;1(3):183-7. https://pubmed.ncbi.nlm.nih.gov/23678425/
17. Pedlar M, Emery MJ, Warburton PJ. Amplifying PCR productivity and environmental sustainability through shortened cycling protocols. Biochimie 2024;221:60-4. https://pubmed.ncbi.nlm.nih.gov/38262587/
18. Boonmee P, Ruangsomboon O, Limsuwat C, Chakorn T. Predictors of mortality in elderly and very elderly emergency patients with sepsis: a retrospective study. West J Emerg Med  2020;21(6):210. https://pubmed.ncbi.nlm.nih.gov/33207168/
19. Martin-Loeches I, Guia MC, Vallecoccia MS, Suarez D, Ibarz M, Irazabal M, et al. Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study. Ann Intensive Care 2019;9(1):26. https://pubmed.ncbi.nlm.nih.gov/30715638/
20. Nasa P, Juneja D, Singh O, Dang R, Arora V. Severe sepsis and its impact on outcome in elderly and very elderly patients admitted in intensive care unit. J Intensive Care Med 2012;27(3):179-83. https://pubmed.ncbi.nlm.nih.gov/21436163/
21. Bacconi A, Richmond GS, Baroldi MA, Laffler TG, Blyn LB, Carolan HE, et al. Improved sensitivity for molecular detection of bacterial and Candida infections in blood. J Clin Microbiol 2014;52(9):3164-74. https://pubmed.ncbi.nlm.nih.gov/24951806/
22. Pechorsky A, Nitzan Y, Lazarovitch T. Identification of pathogenic bacteria in blood cultures: comparison between conventional and PCR methods. J Microbiol Methods 2009;78(3):325-30. https://pubmed.ncbi.nlm.nih.gov/19616588/
23. Lehmann LE, Hunfeld KP, Steinbrucker M, Brade V, Book M, Seifert H, et al. Improved detection of blood stream pathogens by real-time PCR in severe sepsis. Intensive Care Med 2010;36:49-56. https://pubmed.ncbi.nlm.nih.gov/19756512/
24. Tanaka H, Katsuragi S, Hasegawa J, Tanaka K, Osato K, Nakata M, et al. The most common causative bacteria in maternal sepsis-related deaths in Japan were group A Streptococcus: A nationwide survey. J Infect Chemother 2019;25(1):41-4. https://pubmed.ncbi.nlm.nih.gov/30377069/
25. Akya A, Rostamian M, Rezaeian S, Ahmadi M, Janatolmakan M, Sharif SA, et al. Bacterial causative agents of neonatal sepsis and their antibiotic susceptibility in neonatal intensive care units (NICUs) and neonatal wards in Iran: A systematic review. Archives of Pediatric Infectious Diseases 2020;8(2).
26. Gheybi S, Fakour Z, Karamyar M, Khashabi J, Ilkhanizadeh B, ASGHARI SF, et al. Coagulase negative Staphylococcus, the most common cause of neonatal septicemia in Urmia, Iran. 2008.
27. Tabatabaei S. Frequency and antimicrobial susceptibility of bacteria isolated from urine, stool, and blood cultures of Rafsanjan University of Medical Sciences laboratories during 2003. Journal of Rafsanjan University of Medical Sciences 2008;7(2):105-12.
28. Ghadiri H, Vaez H, Khosravi S, Soleymani E. The antibiotic resistance profiles of bacterial strains isolated from patients with hospital-acquired bloodstream and urinary tract infections. Crit Care Res Pract 2012;2012(1):890797. https://pubmed.ncbi.nlm.nih.gov/23304471/
29. Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR, Sauver JLS, Wilson WR, et al. Age-and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med  2007;167(8):834-9. https://pubmed.ncbi.nlm.nih.gov/17452548/
30. Lee CC, Wang JL, Lee CH, Hung YP, Hong MY, Chang CM, et al. Age-related trends in adults with community-onset bacteremia. Antimicrob Agents Chemother 2017;61(12):e01050-17.  https://pubmed.ncbi.nlm.nih.gov/28923864/
31. Alrebish SA, Ahmed NJ, Al Hamed H, Kumar A, Yusufoglu HS, Khan AH. Antibiotic Susceptibility of Bacterial Pathogens Stratified by Age in a Public Hospital in Qassim. Healthcare (Basel) 2022 Sep 13;10(9):1757. https://pubmed.ncbi.nlm.nih.gov/36141370/
32. Leekha S, Standiford HC. Empiric antimicrobial therapy for Gram-negative sepsis: back to the future. Crit Care Med 2011;39(8):1995-6. https://pubmed.ncbi.nlm.nih.gov/21768802/
33. Dualleh N, Chanchiri I, Skjøt-Arkil H, Pedersen AK, Rosenvinge FS, Johansen IS. Colonization with multiresistant bacteria in acute hospital care: the association of prior antibiotic consumption as a risk factor. J Antimicrob Chemother 2020;75(12):3675-81. https://pubmed.ncbi.nlm.nih.gov/32814968/
34. Johnson MT, Reichley R, Hoppe-Bauer J, Dunne WM, Micek S, Kollef M. Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis. Crit Care Med 2011;39(8):1859-65. https://pubmed.ncbi.nlm.nih.gov/21499086/
35. Mellhammar L, Kahn F, Whitlow C, Kander T, Christensson B, Linder A. Bacteremic sepsis leads to higher mortality when adjusting for confounders with propensity score matching. Sci Rep 2021;11(1):6972. https://pubmed.ncbi.nlm.nih.gov/33772090/
36. Adwan G, Hasan NA, Sabra I, Sabra D, Al-butmah S, Odeh S, et al. Detection of bacterial pathogens in surgical site infections and their antibiotic sensitivity profile. Int J Med Res Health Sci 2016;5(5):75-82.
37. Chou EH, Mann S, Hsu TC, Hsu WT, Liu CCY, Bhakta T, et al. Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: A nationwide study. PloS One 2020;15(1):e0227752. https://pubmed.ncbi.nlm.nih.gov/31929577/
38. Rabee HA, Tanbour R, Nazzal Z, Hamshari Y, Habash Y, Anaya A, et al. Epidemiology of sepsis syndrome among intensive care unit patients at a tertiary University Hospital in Palestine in 2019. Indian J Crit Care Med 2020;24(7):551-6. https://pubmed.ncbi.nlm.nih.gov/32963438/
39. Varmazyar-najafi M, Pajohi-alamoti M, Mohammadzadeh A, Mahmoodi P. Detection of Methicillin-Resistance Gene in Staphylococcus aureus Isolated from Traditional White Cheese in Iran. Archives of Hygiene Sciences 2016;5(4).
40. Behshood P, Tajbakhsh E, Momtaz H. Recognition of (Sesc) for easy identification of Staphylococcus epidermidis and molecular and phenotypic study of Β-Lactam resistance in Staphylococcus epidermidis isolates in Isfahan. Rep Biochem Mol Biol 2020;9(3):309-14. https://pubmed.ncbi.nlm.nih.gov/33649724/
41. Le Gall F, Le Berre R, Rosec S, Hardy J, Gouriou S, Boisramé-Gastrin S, et al. Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis. BMC Microbiol 2013;13(1):1-9. https://pubmed.ncbi.nlm.nih.gov/24088260/
42. Siu LK, Fung CP, Chang FY, Lee N, Yeh KM, Koh TH, et al. Molecular typing and virulence analysis of serotype K1 Klebsiella pneumoniae strains isolated from liver abscess patients and stool samples from noninfectious subjects in Hong Kong, Singapore, and Taiwan. J Clin Microbiol 2011;49(11):3761-5. https://pubmed.ncbi.nlm.nih.gov/21900521/
43. Bøving MK, Pedersen LN, Møller JK. Eight-plex PCR and liquid-array detection of bacterial and viral pathogens in cerebrospinal fluid from patients with suspected meningitis. J Clin Microbiol 2009;47(4):908-13. https://pubmed.ncbi.nlm.nih.gov/19193844/